Your browser doesn't support javascript.
loading
Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data.
Campioni, M; Agirrezabal, I; Hajek, R; Minarik, J; Pour, L; Spicka, I; Gonzalez-McQuire, S; Jandova, P; Maisnar, V.
Afiliación
  • Campioni M; Economic Modeling Center of Excellence, Global Health Economics, Amgen (Europe) GmbH, Zug, Switzerland. campioni@amgen.com.
  • Agirrezabal I; Economic Modeling Center of Excellence, Global Health Economics, Amgen (Europe) GmbH, Zug, Switzerland.
  • Hajek R; Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, 17. listopadu 1790, 708 52, Ostrava, Czech Republic.
  • Minarik J; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, I. P. Pavlova 185/6, 779 00, Olomouc, Czech Republic.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine Masaryk Universit, Jihlavská 340/20, 625 00, Brno, Czech Republic.
  • Spicka I; Department of Internal Medicine, Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, Katerinska 32, 121 08, Prague, Czech Republic.
  • Gonzalez-McQuire S; Global Health Economics, Amgen (Europe) GmbH, Zug, Switzerland.
  • Jandova P; Amgen s.r.o, Prague, Czech Republic.
  • Maisnar V; Department of Internal Medicine, Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, Katerinska 32, 121 08, Prague, Czech Republic.
Eur J Health Econ ; 21(2): 219-233, 2020 Mar.
Article en En | MEDLINE | ID: mdl-31673898
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Dexametasona / Análisis Costo-Beneficio / Lenalidomida / Mieloma Múltiple Tipo de estudio: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Health Econ Asunto de la revista: SAUDE PUBLICA / SERVICOS DE SAUDE Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligopéptidos / Dexametasona / Análisis Costo-Beneficio / Lenalidomida / Mieloma Múltiple Tipo de estudio: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Health Econ Asunto de la revista: SAUDE PUBLICA / SERVICOS DE SAUDE Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Alemania